zur Navigation zur Suche zum Inhalt

Aussteller- und


Link teilen

Per E-Mail weiterempfehlenEmpfehlen

Weiterempfehlen von iCELLis® 500+ bioreactor system

Trennen Sie mehrere E-Mail-Adressen durch ein Komma voneinander. Die Empfänger erhalten einen Link zu dieser Plattform.

* erforderlich

Ihre Empfehlung wurde erfolgreich versendet.


The new and improved iCELLis 500+ bioreactor system will simplify large scale cGMP production of virus for vaccines or gene therapy. New features provide enhanced robust control, reliability, and sustainability of high-density adherent cell growth, enabling customers to further automate processes for cell and gene therapy.






Pall Biotech offers a blend of innovative traditional, single-use and continuous processing technologies and services to create scalable bioprocessing solutions that are flexible to each type of manufacturer’s process. From concept through to design, validation and production, our team leverages best-inclass technologies with industry-leading support for all bioprocessing applications. Whether that means fast-tracking a new drug, helping to ensure regulatory compliance, or making existing processes easier, faster and better, we are ready to fulfill your unique needs.
Want to learn more about how Pall Biotech can enhance your bioprocesses from start to finish?
Please visit our homepage.

Kontaktieren Sie uns

Persönliche Angaben

* erforderlich

Ihr Anliegen
Nachricht senden
Ihre Anfrage wurde erfolgreich versendet.

Zum Aussteller